user

Use of Faricimab in the real-world clinical practice for non-treatment naive neovascular age-related macular degeneration patients

被引：0
|
作者：
Tran, Donald [1 ]
Trung M. Dang [1 ]
Moodie, Jonathan [1 ]
Luckie, Alan [1 ]
机构：
[1] Eye Clin Albury Wodonga, Albury, NSW, Australia
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2023年 / 51卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1020 / 1020
页数：1
相关论文
共 50 条
  • [41] Faricimab in Treatment -Experienced Neovascular Age -Related Macular Degeneration
    Qaseem, Yaqoob
    Pettenkofer, Moritz
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [42] Real -world efficacy of switching to faricimab therapy in patients with longstanding neovascular age -related macular degeneration
    Long Phan
    Chin, Jennifer
    Hong, Thomas
    Chang, Andrew
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [43] Three-Year Real World Outcomes of Aflibercept Treatment of Treatment-naive Patients with Neovascular Age-related Macular Degeneration
    Eleftheriadou, Maria
    Gemenetzi, Maria K.
    Sivaprasad, Sobha
    Hykin, Philip G.
    Hamilton, Robin
    Tufail, Adnan
    Patel, Praveen J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [44] Consequences of Real-World Surveillance of Fellow Eyes in Neovascular Age-Related Macular Degeneration
    Onwuka, Oluchukwu
    Saddemi, Jackson L.
    Aydogmus, Fatma Sema Akkan
    Lasalle, Claudia C.
    Ramsey, David J.
    LIFE-BASEL, 2023, 13 (02):
  • [45] Treatment of naive lesions in neovascular age-related macular degeneration with pegaptanib
    Quiram, Polly A.
    Hassan, Tarek S.
    Williams, George A.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (07): : 851 - 856
  • [46] Exit Strategy for Treatment of Neovascular Age-Related Macular Degeneration in a Real-World Setting: Wishful Thinking?
    Eastline, Michael
    Said, Sadiq
    Bosch, Martina Monika
    Pascal, Knecht-Bosch
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2025,
  • [47] Consequences of Real-world Surveillance of Fellow Eyes in Neovascular Age-related Macular Degeneration
    Onwuka, Oluchukwu
    Saddemi, Jackson
    Akkan, F. Sema
    Lasalle, Claudia
    Ramsey, David J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [48] Clinical Outcomes Following a Switch of Therapy to Faricimab in Patients Affected by Neovascular Age-Related Macular Degeneration
    Wolfrum, Peter
    Boehm, Elsa Wilma
    Lorenz, Katrin
    Stoffelns, Bernhard
    Pfeiffer, Norbert
    Korb, Christina A.
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
  • [49] Factors Involved in Anti-VEGF Treatment Decisions for Neovascular Age-Related Macular Degeneration: Insights from Real-World Clinical Practice
    Yiu, Glenn
    Gulati, Shilpa
    Higgins, Victoria
    Coak, Emily
    Mascia, Daniel
    Kim, Eunice
    Spicer, Galin
    Tabano, David
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 1679 - 1690
  • [50] Ranibizumab in patients with neovascular age-related macular degeneration: results from the real-world LUMINOUS™ study
    Souied, E.
    Clemens, A.
    Macfadden, W.
    ACTA OPHTHALMOLOGICA, 2017, 95
12345